News Quantified

Stock Stats

News Stats


All News	{{AllNewsCount}}
News Wires	{{NewsWiresCount}}
Media Monitoring	{{MoreOverCount}}
SEC Edgar Filings	{{SecEdgarFilingsCount}}
Upgrades	{{UpgradesCount}}
Downgrades	{{DowngradesCount}}
Initiated	{{InitiatesCount}}
Reiterated	{{ReiteratesCount}}
Last Earnings	{{LastEarnings}}
Last Earnings EPS	{{LastEps}}
Next Earnings	{{NextEarnings}}

Order Stats

Sub-Penny
{{SubPennyStr}}
Odd Lot
{{OddLotStr}}
Avg. bid-ask spread

{{GetAvgBidAskSpreadForScale}}
Avg. bid / ask size
{{GetAvgBidSizeForScale}} {{GetAvgAskSizeForScale}}

Shares at ask / bid
{{SharesAtAsk_AMP_Str}} {{SharesAtBid_AMP_Str}}
Off exchange
{{OffExchange}}

News

Alto Neuroscience Announces New Employee Inducement Grants Under NYSE Rule 303A.08

Johnson Fistel, PLLP Investigates Claims on Behalf of Long-Term Shareholders of Alto Neuroscience, Inc. (ANRO), Atkore Inc. (ATKR), Dow Inc. (DOW), and Fly-E Group, Inc. (FLYE)

Alto Neuroscience (NYSE:ANRO) was upgraded by analysts at Chardan Capital to a "strong-buy" rating.

Alto Neuroscience (NYSE:ANRO) is now covered by analysts at BTIG Research. They set a "buy" rating and a $27.00 price target on the stock.

Alto Neuroscience (NYSE:ANRO) was upgraded by analysts at Wall Street Ze

11/12/2025

07:57 am

anro

2.6%

BEAT

8/13/2025

04:10 pm

anro

-0.3%

MISS

5/14/2025

04:10 pm

anro

10.5%

BEAT

Form S-3 Alto Neuroscience, Inc.

Form 10-Q Alto Neuroscience, Inc. For: Sep 30

Form 8-K Alto Neuroscience, Inc. For: Nov 12

Form D Alto Neuroscience, Inc.

Form SCHEDULE 13G Alto Neuroscience, Inc. Filed by: Commodore Capital LP

52 Week High	{{GetCompanyStockInfo.Week52HighValue}} {{GetCompanyStockInfo.Week52HighDate}}
52 Week Low	{{GetCompanyStockInfo.Week52LowValue}} {{GetCompanyStockInfo.Week52LowDate}}

Today’s Volatility	{{VolatilityStr}}
20 Day Volatility	{{Volatility20Str}}

Open	{{GetCompanyStockInfo.Open}}
Prior Close	{{GetCompanyStockInfo.PriorCloseValue}} {{GetCompanyStockInfo.PriorCloseDate}}